PSEUDOHYPOALDOSTERONISM

PSEUDOHYPOALDOSTERONISM

- Pseudohypoaldosteronism (P'HA) is referred to a state of endorgan unresponsiveness to aldosterone. In this article a 12 day - old mule newborn is presented with hyponatremia, hyperkalemia and metabolic acidosis. Aldosterone level and plasma renin activity were high. Mineralocorticoids had no...

Full description

Bibliographic Details
Main Authors:	A. Rabbani., B. Goharfar, A. Dehgani
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 1996-12-01
Series:	Acta Medica Iranica
Subjects:	renin aldosterone
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/1705

Similar Items

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Comparison between screening for primary aldosteronism with and without drug adjustment
by: Yanlong Hua, et al.
Published: (2024-12-01)

Low plasma renin activity is associated with “Apparently” idiopathic atrial fibrillation
by: Youmei Shen, et al.
Published: (2023-12-01)

Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trialResearch in context
by: Paolo Mulatero, et al.
Published: (2024-05-01)

RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01)

Indicators of humoral regulation of the circulatory system in obese patients
by: Tatyana S. Zaletova, et al.
Published: (2020-06-01)

Who needs to be screened for primary aldosteronism?
by: Wei-Chieh Huang, et al.
Published: (2024-03-01)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Wei‐Chieh Huang, et al.
Published: (2022-09-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Low renin hypertension
by: Manisha Sahay, et al.
Published: (2012-01-01)

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
by: Gregory P. Veldhuizen, et al.
Published: (2021-02-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
by: Adina F. Turcu, et al.
Published: (2022-07-01)

Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1‐7)/MAS receptor axes in human mesangial cells
by: Danielle Stoll, et al.
Published: (2019-06-01)

RAAS in diabetic retinopathy: mechanisms and therapies
by: Xin Li, et al.
Published: (2024-06-01)

EVOLUTION STAGES OF LOW RENIN HYPERTENSION
by: S. V. Akhadov, et al.
Published: (2016-01-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Implications of Plasma Renin Activity and Plasma Aldosterone Concentration in Critically Ill Patients with Septic Shock
by: Kyung Soo Chung, et al.
Published: (2017-05-01)

SYMPATHO-ADRENAL SYSTEM IN ARTERIAL HYPERTENSION PATIENTS: ACTIVITY ASSESSMENT AND CLINICAL VALUE
by: Sh. V. Akhadov, et al.
Published: (2009-04-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension
by: Christian Beger, et al.
Published: (2023-12-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Adiposity, aldosterone and plasma renin activity among African Americans: The Jackson Heart Study
by: Grace Lee, et al.
Published: (2023-06-01)

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2019-07-01)

THE CORRELATION BETWEEN THE RENIN AT ALDOSTERONE SYSTEM – ARTERIAL HYPERTENSION AND HORMONAL MECHANISMS
by: Liviu Stafie, et al.
Published: (2024-09-01)

Aldosterone-Mediated Sodium Retention Is Reflected by the Serum Sodium to Urinary Sodium to (Serum Potassium)<sup>2</sup> to Urinary Potassium (SUSPPUP) Index
by: Evelien Kanaan, et al.
Published: (2020-07-01)

Primary Aldosteronism: A Series of 11 Cases
by: Abhranil Dhar, et al.
Published: (2023-09-01)

First Trimester Renin and Aldosterone Levels of Pregnant Women With Prognosis of Preeclampsia and/or Related Adverse Pregnancy Outcomes
by: Yunus Emre Purut, et al.
Published: (2017-06-01)

Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports
by: Tomoko Yamada, et al.
Published: (2020-09-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan
by: Gu N, et al.
Published: (2016-04-01)

Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
by: Zige Liu, et al.
Published: (2024-01-01)

The impact of progestogens on RAAS – a systematic review
by: Adrian Singer, et al.
Published: (2025-02-01)

Cutoff Values of Aldosterone and the Aldosterone–Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study
by: João Vicente da Silveira, et al.
Published: (2024-09-01)

Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension
by: Dien Yan, et al.
Published: (2024-04-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01)

RENIN AND ALDOSTERONE PRODUCTION IN CHILDREN WITH HYDRONEPHROSIS WITH RELATION TO THE SEVERITY OF NON-DIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA AND TIME OF URINAL OBSTRUCTION ELIMINATION
by: A.M. Mambetova, et al.
Published: (2011-11-01)